HIGHLIGHTS
- who: Ricardo Ruiz-Villaverde et al. from the (UNIVERSITY) have published the research: Atopic Dermatitis: Background, Objectives and Future Perspectives (Superresponders), in the Journal: Life 2022, 12, 1192. of 31/07/2022
- what: Sensitization to Malassezia furfur may be one of the main reasons, especially in patients being treated with dupilumab. Ayen-Rodriguez et_al complete this issue by expanding the systematic review and network meta-analysis initially carried out by Pereyra et_al , but with much more limited data in the evaluation of efficacy and safety at 52 weeks. The aim of this study was to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.